Pharma MedComms World Europe 2011 - The big idea

There are a high number of top-industry players at Pharma MedComms World Europe 2011 ready to discuss proven ways of making your medical communications strategy work including representatives from: Pfizer, Abbott, Eli Lilly & Co. Novartis, Sanofi Aventis, Bristol-Myers Squibb, Baxter, Eisai, Amgen, GSK, AstraZeneca, Biogen Idec, Novo Nordisk and Boehringer Ingelheim.

Don’t miss out on gaining extensive knowledge on how to work with a diverse range of healthcare organisations in order to deliver an effective medical communication strategy.

>> Register now

Key issues to be address include:

- Needs of the patient versus needs of the industry
- The informed patient – the role of media coverage and PR
- Preserving industry reputation in a world of transparency and blame
- Directing communication programmes to local decision-makers
- Value-based purchasing
- Providing the right medical information to patients
- Disease and treatment awareness campaigns
- How CME can change professional behaviour & improve patient care
- Best practice in medical publications
- Ethics and transparency in publishing industry
- Strategic partnerships with KOLs
- The evolution of open access in publications
- Effective medical writing in journal publishing, regulatory submissions

Don’t miss out. Learn the best way to conduct your medical communication strategy at Pharma MedComms World Europe 2011!

>> Download the brochure now

>> Register now 

Pharma MedComms World Europe 2011 is co-located with Digipharm Europe 2011, the only strategic digital marketing conference for pharma marketers.